CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today published the offer prospectus regarding its public tender offer for all publicly held registered shares of Vifor Pharma Ltd. (SIX:VIFN; ISIN:CH0364749348)...
or just over one third (0.37x) of Commonwealth Bank. Of course, the difference can be explained by low rates and growth expectations but with the price to earnings ratio of CSL being 2.6 times